Video
Author(s):
Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.
Stay up to date on cancer updates, research and education
Optimal Jakafi Dosing Associated With Improved Outcomes in Myelofibrosis
FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis
Jakafi May Not Associate with Long-Term Benefits in Myelofibrosis Subset
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
Subcutaneous Dacogen Elicits Responses Among Some With Myelofibrosis
P1101 Treatment Meets Phase 3 Primary End Point in Essential Thrombocythemia